Fig. 1
From: Limitations of applying the COX proportional hazards model to glioma studies
Construction and evaluation of the nomogram. (A) Nomogram for 1-, 3-, and 5-year OS based on IDH status, primary therapy outcome, age, and SIRPB1 expression. (B) Calibration curves showed the concordance between predicted and observed 1-, 3-, and 5-year OS